Journal Article

Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

George Apostol; Walid Abi-Saab; Christopher J. Kratochvil; Lenard A. Adler; Weining Z. Robieson; Laura M. Gault; Yili L. Pritchett; David Feifel; Michelle A. Collins; Mario D. Saltarelli

Psychopharmacology · Vol. 219, Issue 3 · pp. 715-725 · 2012

View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

Journal	Psychopharmacology
Publisher	Springer
Publication Date	2012-02-01
Publication Year	2012
Volume	219
Issue	3
Pages	715-725
Document Type	Journal Article
Print ISSN	0033-3158
eISSN	1432-2072
DOI	10.1007/s00213-011-2393-2

Access Information

NARA Access Coverage	1959-01-01~Current
Journal Homepage	https://www.springer.com/journal/213
Publisher Page	Open Publisher Page

Full-text access depends on NARA's subscribed coverage and institutional access.